Targeting alternative splicing in cancer immunotherapy

Tumor immunotherapy has made great progress in cancer treatment but still faces several challenges, such as a limited number of targetable antigens and varying responses among patients. Alternative splicing (AS) is an essential process for the maturation of nearly all mammalian mRNAs. Recent studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Nan, Liu, Zhaoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450511/
https://www.ncbi.nlm.nih.gov/pubmed/37635865
http://dx.doi.org/10.3389/fcell.2023.1232146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450511/
https://www.ncbi.nlm.nih.gov/pubmed/37635865
http://dx.doi.org/10.3389/fcell.2023.1232146

Ejemplares similares